Buprenorphine for Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Patients: Does It Serve as a Bridge to Hepatitis C Virus Therapy?

OBJECTIVES: Buprenorphine is associated with enhanced human immunodeficiency virus (HIV) treatment outcomes including increased antiretroviral therapy initiation rates, adherence, and CD4(+) cell counts among HIV-infected opioid-dependent individuals. Buprenorphine facilitates hepatitis C virus (HCV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Taylor, Lynn E., Maynard, Michaela A., Friedmann, Peter D., MacLeod, Cynthia J., Rich, Josiah D., Flanigan, Timothy P., Sylvestre, Diana L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209296/
https://ncbi.nlm.nih.gov/pubmed/22614935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ADM.0b013e318257377f
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados